Inspiremd Stock Investor Sentiment

NSPR Stock  USD 2.77  0.06  2.21%   
Slightly above 55% of InspireMD's retail investors are presently thinking to get in. The analysis of overall sentiment of trading InspireMD stock suggests that some investors are interested at this time. InspireMD's investing sentiment overview a quick insight into current market opportunities from investing in InspireMD. Many technical investors use InspireMD stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
over six months ago at news.google.com         
InspireMDs CE Mark Recertification to Boost CGuard EPS - Zacks Investment Research
Google News at Macroaxis
over six months ago at news.google.com         
InspireMD Secures CE Mark Recertification Under New EU Standards - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at massdevice.com         
InspireMD wins CE mark for carotid stent system
news
over six months ago at finance.yahoo.com         
InspireMD Receives CE Mark Recertification Under EUs New Medical Device Regulation Regulatory Framew...
Yahoo News
over six months ago at www.macroaxis.com         
Acquisition by Paul Stuka of 43548 shares of InspireMD subject to Rule 16b-3
Macroaxis News
over six months ago at finance.yahoo.com         
Were Hopeful That InspireMD Will Use Its Cash Wisely
Yahoo News
over six months ago at news.google.com         
Should You Hold InspireMD Inc in Medical Devices Industry - InvestorsObserver
Google News at Macroaxis
over six months ago at simplywall.st         
Heres Why Were Not Too Worried About InspireMDs Cash Burn Situation
Simply Wall St News at Macroaxis
over a year ago at news.google.com         
InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice Presi...
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
20,000 Shares in InspireMD, Inc. Purchased by Avestar Capital LLC
news
over a year ago at thelincolnianonline.com         
StockNews.com Begins Coverage on InspireMD
news
over a year ago at news.google.com         
Where Will InspireMD Inc Stock Go Next After It Is Higher By 16.51 percent in a Week - InvestorsObse...
Google News at Macroaxis
over a year ago at globenewswire.com         
InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard Neuroprotection System
Macroaxis News: globenewswire.com
over a year ago at benzinga.com         
InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard Neuroprotection System
benzinga news
over a year ago at finance.yahoo.com         
InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard Neuroprotection System
Yahoo News
Far too much social signal, news, headlines, and media speculation about InspireMD that are available to investors today. That information is available publicly through InspireMD media outlets and privately through word of mouth or via InspireMD internal channels. However, regardless of the origin, that massive amount of InspireMD data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of InspireMD news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of InspireMD relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to InspireMD's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive InspireMD alpha.

InspireMD Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.